These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23695978)

  • 41. Self-assembled plasmonic vesicles of SERS-encoded amphiphilic gold nanoparticles for cancer cell targeting and traceable intracellular drug delivery.
    Song J; Zhou J; Duan H
    J Am Chem Soc; 2012 Aug; 134(32):13458-69. PubMed ID: 22831389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tubular polymersomes: a cross-linker-induced shape transformation.
    van Oers MC; Rutjes FP; van Hest JC
    J Am Chem Soc; 2013 Nov; 135(44):16308-11. PubMed ID: 24156517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exposing the tumor microenvironment: how gold nanoparticles enhance and refine drug delivery.
    Tamarkin L; I Kingston DG
    Ther Deliv; 2017 Jun; 8(6):363-366. PubMed ID: 28530147
    [No Abstract]   [Full Text] [Related]  

  • 44. Metal based frameworks for drug delivery systems.
    Popescu RC; Grumezescu AM
    Curr Top Med Chem; 2015; 15(15):1532-42. PubMed ID: 25877086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy.
    Van de Broek B; Devoogdt N; D'Hollander A; Gijs HL; Jans K; Lagae L; Muyldermans S; Maes G; Borghs G
    ACS Nano; 2011 Jun; 5(6):4319-28. PubMed ID: 21609027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azide-derivatized gold nanorods: functional materials for "click" chemistry.
    Gole A; Murphy CJ
    Langmuir; 2008 Jan; 24(1):266-72. PubMed ID: 18052398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new anti-cancer strategy of damaging mitochondria by pro-apoptotic peptide functionalized gold nanoparticles.
    Chen WH; Chen JX; Cheng H; Chen CS; Yang J; Xu XD; Wang Y; Zhuo RX; Zhang XZ
    Chem Commun (Camb); 2013 Jul; 49(57):6403-5. PubMed ID: 23752706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.
    Lu RM; Chang YL; Chen MS; Wu HC
    Biomaterials; 2011 Apr; 32(12):3265-74. PubMed ID: 21306768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fast copper-free click DNA ligation by the ring-strain promoted alkyne-azide cycloaddition reaction.
    Shelbourne M; Chen X; Brown T; El-Sagheer AH
    Chem Commun (Camb); 2011 Jun; 47(22):6257-9. PubMed ID: 21547301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Near-IR remote release from assemblies of liposomes and nanoparticles.
    Volodkin DV; Skirtach AG; Möhwald H
    Angew Chem Int Ed Engl; 2009; 48(10):1807-9. PubMed ID: 19173270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clickable gold nanoparticles as the building block of nanobioprobes.
    Zhang MX; Huang BH; Sun XY; Pang DW
    Langmuir; 2010 Jun; 26(12):10171-6. PubMed ID: 20441155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex.
    Kim JY; Shim G; Choi HW; Park J; Chung SW; Kim S; Kim K; Kwon IC; Kim CW; Kim SY; Yang VC; Oh YK; Byun Y
    Biomaterials; 2012 Jun; 33(17):4424-30. PubMed ID: 22425551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pointing in the Right Direction: Controlling the Orientation of Proteins on Nanoparticles Improves Targeting Efficiency.
    Yong KW; Yuen D; Chen MZ; Porter CJH; Johnston APR
    Nano Lett; 2019 Mar; 19(3):1827-1831. PubMed ID: 30773887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cycloaddition reactivity studies of first-row transition metal-azide complexes and alkynes: an inorganic click reaction for metalloenzyme inhibitor synthesis.
    Evangelio E; Rath NP; Mirica LM
    Dalton Trans; 2012 Jul; 41(26):8010-21. PubMed ID: 22517535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanobody Conjugates for Targeted Cancer Therapy and Imaging.
    Kang W; Ding C; Zheng D; Ma X; Yi L; Tong X; Wu C; Xue C; Yu Y; Zhou Q
    Technol Cancer Res Treat; 2021; 20():15330338211010117. PubMed ID: 33929911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Site-Selective Functionalization of Nanobodies Using Intein-Mediated Protein Ligation for Innovative Bioconjugation.
    Graulus GJ; Ta DT; Tran H; Hansen R; Billen B; Royackers E; Noben JP; Devoogdt N; Muyldermans S; Guedens W; Adriaensens P
    Methods Mol Biol; 2019; 2033():117-130. PubMed ID: 31332751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytotoxic tumor targeting with scFv antibody-modified liposomes.
    Marty C; Schwendener RA
    Methods Mol Med; 2005; 109():389-402. PubMed ID: 15585933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.